Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.11
  • Today's Change-0.03 / -2.63%
  • Shares traded6.16m
  • 1 Year change+180.59%
  • Beta3.7337
Data delayed at least 15 minutes, as of Sep 20 2024 21:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Ocugen Inc fell by 38.10m. Cash Flow from Financing totalled 20.88m or 345.94% of revenues. In addition the company used 62.05m for operations while cash from investing totalled 3.08m.
Cash flow per share-0.1936
Price/Cash flow per share--
Book value per share0.0658
Tangible book value per share0.0658
More ▼

Balance sheet in USDView more

Ocugen Inc appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio1.04
Quick ratio--
Total debt/total equity0.1688
Total debt/total capital0.1445
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.